SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines - Quaterly Results

14 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 6.46 million declined by -79.58% from Rs. 31.64 millions.The Net Loss for the quarter ended December 2023 is Rs. -2.71 millions as compared to Net Loss of Rs. -2.02 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -0.40% as compared to 3.39% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 6.46 31.64 -79.58 41.47 71.45 -41.96 83.58 94.38 -11.44
Other Income 0.00 0.03 0.00 0.00 0.03 0.00 0.14 0.26 -46.15
PBIDT -0.40 3.39 -111.80 -6.72 3.80 -276.84 9.38 -0.46 -2139.13
Interest 0.86 3.90 -77.95 2.58 11.31 -77.19 15.00 14.82 1.21
PBDT -1.26 -0.51 147.06 -9.30 -7.51 23.83 -5.62 -15.28 -63.22
Depreciation 1.45 1.51 -3.97 4.33 4.53 -4.42 6.30 6.57 -4.11
PBT -2.71 -2.02 34.16 -13.63 -12.04 13.21 -11.92 -21.85 -45.45
TAX 0.00 0.00 0.00 0.00 0.00 0.00 5.56 10.79 -48.47
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 5.56 10.79 -48.47
PAT -2.71 -2.02 34.16 -13.63 -12.04 13.21 -17.48 -32.64 -46.45
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -6.19 10.71 -157.79 -16.20 5.32 -404.69 11.22 -0.49 -2402.59

Norris Medicines Share Price

14.22 -0.02 (-0.14%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×